Cytokinetics Inc (CYTK)

Mar 07, 2025

Morgan Stanley raises Cytokinetics stock to Overweight, $67 target By Investing.com - Investing.com UK

Mar 07, 2025

Mar 05, 2025

Insider Sell Alert: Fady Malik Sells Shares of Cytokinetics Inc (CYTK) - GuruFocus.com

Mar 05, 2025

Mar 05, 2025

Insider Sell: Andrew Callos Sells Shares of Cytokinetics Inc (CY - GuruFocus.com

Mar 05, 2025

Mar 05, 2025

Cytokinetics EVP Callos sells $47,768 in stock - Investing.com

Mar 05, 2025

Mar 05, 2025

Cytokinetics CEO Robert Blum sells $1.08 million in stock - Investing.com

Mar 05, 2025

Mar 05, 2025

Insider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK) - GuruFocus.com

Mar 05, 2025

Mar 05, 2025

Revenue Downgrade: Here's What Analysts Forecast For Cytokinetics, Incorporated (NASDAQ:CYTK) - Yahoo Finance

Mar 05, 2025

Mar 04, 2025

Cytokinetics EVP sells $85,000 in stock By Investing.com - Investing.com South Africa

Mar 04, 2025

Mar 04, 2025

Cytokinetics EVP sells $85,000 in stock - Investing.com India

Mar 04, 2025

Mar 03, 2025

Cytokinetics Q4 Loss Wider Than Expected, Aficamten in Focus - MSN

Mar 03, 2025

Mar 03, 2025

Cytokinetics to Participate in March Investor Conferences - The Manila Times

Mar 03, 2025

Mar 03, 2025

Where Can You Hear Cytokinetics' Latest Strategy? Three Upcoming Investor Conferences Revealed - StockTitan

Mar 03, 2025

Mar 01, 2025

Cytokinetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Mar 01, 2025

Mar 01, 2025

HC Wainwright Reaffirms Buy Rating for Cytokinetics (NASDAQ:CYTK) - MarketBeat

Mar 01, 2025

Feb 28, 2025

Impax Asset Management Group plc Acquires 50,000 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) - MarketBeat

Feb 28, 2025

Feb 28, 2025

Cytokinetics (NASDAQ:CYTK) Posts Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

Smart Money Is Betting Big In CYTK Options - Benzinga

Feb 28, 2025

Feb 28, 2025

Oppenheimer Adjusts Price Target on Cytokinetics to $96 From $98, Maintains Outperform Rating - Marketscreener.com

Feb 28, 2025

Feb 28, 2025

Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

Feb 28, 2025

Cytokinetics’ Mixed Outlook: Hold Rating Amid Execution Challenges and Modest Trial Impact - TipRanks

Feb 28, 2025

Feb 28, 2025

Cytokinetics Inc (CYTK) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses - Yahoo Finance

Feb 28, 2025

Feb 28, 2025

Cytokinetics’ Promising Pipeline and Strategic Expansion Drive Buy Rating - TipRanks

Feb 28, 2025

Feb 28, 2025

Cytokinetics Inc (CYTK) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses By GuruFocus - Investing.com Canada

Feb 28, 2025

Feb 28, 2025

Decoding Cytokinetics Inc (CYTK): A Strategic SWOT Insight - GuruFocus.com

Feb 28, 2025

Feb 28, 2025

Cytokinetics: Q4 Earnings Snapshot - The Washington Post

Feb 28, 2025

Feb 28, 2025

Cytokinetics plans mixed shelf offering - MSN

Feb 28, 2025

Feb 27, 2025

Cytokinetics Reports 2024 Financials and Strategic Progress - TipRanks

Feb 27, 2025

Feb 27, 2025

Cytokinetics Inc earnings missed by $0.04, revenue topped estimates - Investing.com Canada

Feb 27, 2025

Feb 27, 2025

CYTKCytokinetics Inc Latest Stock News & Market Updates - StockTitan

Feb 27, 2025

Feb 27, 2025

Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates - MSN

Feb 27, 2025

Feb 27, 2025

Cytokinetics reports Q4 EPS ($1.26), consensus ($1.17) - TipRanks

Feb 27, 2025

Feb 27, 2025

Cytokinetics Files For Mixed ShelfSEC Filing - TradingView

Feb 27, 2025

Feb 27, 2025

CYTOKINETICS INC SEC 10-K Report - TradingView

Feb 27, 2025

Feb 27, 2025

Cytokinetics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025

Feb 27, 2025

Cytokinetics reports Q4 revenue beat, EPS miss; shares flat By Investing.com - Investing.com Canada

Feb 27, 2025

Feb 27, 2025

Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Feb 27, 2025

Feb 27, 2025

Investor Network: Cytokinetics, Incorporated to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Cytokinetics Q4 2024 Earnings Preview - MSN

Feb 27, 2025

Feb 26, 2025

Cytokinetics Inc (CYTK) Q4 2024: Everything You Need To Know Ahe - GuruFocus.com

Feb 26, 2025

Feb 26, 2025

Cytokinetics Inc (CYTK) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Feb 26, 2025

Feb 26, 2025

Cytokinetics' SWOT analysis: aficamten's potential reshapes HCM treatment landscape - Investing.com

Feb 26, 2025

Feb 25, 2025

Cytokinetics, Incorporated (NASDAQ:CYTK) Shares Purchased by Rhumbline Advisers - MarketBeat

Feb 25, 2025

Feb 25, 2025

Analysts Set Cytokinetics, Incorporated (NASDAQ:CYTK) Target Price at $82.00 - MarketBeat

Feb 25, 2025

Feb 24, 2025

Cytokinetics (NASDAQ:CYTK) Trading 7.4% HigherHere's What Happened - MarketBeat

Feb 24, 2025

Feb 23, 2025

Cytokinetics, Incorporated (CYTK): the Most Oversold Pharma Stock to Buy According to Analysts - MSN

Feb 23, 2025

Feb 22, 2025

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - MSN

Feb 22, 2025

Feb 21, 2025

Cytokinetics (CYTK) Projected to Post Earnings on Tuesday - MarketBeat

Feb 21, 2025

Feb 21, 2025

Allspring Global Investments Holdings LLC Has $4.11 Million Stake in Cytokinetics, Incorporated (NASDAQ:CYTK) - MarketBeat

Feb 21, 2025

Feb 21, 2025

Cytokinetics, Incorporated (NASDAQ:CYTK) Shares Sold by Van ECK Associates Corp - MarketBeat

Feb 21, 2025